MARKET

IVVD

IVVD

Invivyd
NASDAQ
2.470
+0.040
+1.65%
After Hours: 2.480 +0.01 +0.40% 19:41 12/31 EST
OPEN
2.410
PREV CLOSE
2.430
HIGH
2.490
LOW
2.370
VOLUME
1.96M
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.3546
MARKET CAP
684.35M
P/E (TTM)
-5.2154
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IVVD last week (1222-1226)?
Weekly Report · 12/29/2025 09:41
Ibio, RLMD, SEE, OLLI, Invivyd Trending With Analysts
TipRanks · 12/27/2025 09:00
Invivyd Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 12/24/2025 11:11
Invivyd Advances VYD2311 With Phase 3 Trial Launch And Fast Track Status
NASDAQ · 12/23/2025 13:46
Invivyd granted FDA fast track status for COVID therapy
Seeking Alpha · 12/23/2025 13:17
Invivyd's COVID-19 Vaccine-Alternative Antibody VYD2311 Granted FDA Fast Track Status
NASDAQ · 12/23/2025 12:32
Invivyd’s COVID Antibody VYD2311 Receives FDA Fast Track
TipRanks · 12/23/2025 12:28
BUZZ-Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody
Reuters · 12/23/2025 12:12
More
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Webull offers Invivyd Inc stock information, including NASDAQ: IVVD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVVD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVVD stock methods without spending real money on the virtual paper trading platform.